Funding Opportunities

Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Targeted cargo delivery to pancreatic islet cells'

November 30, 2021

CALL FOR PROPOSALS

2022 HSCI DIABETES PROGRAM PILOT GRANTS

 

'Targeted cargo delivery to pancreatic islet cells'

 

AWARD AMOUNT

Up to $100,000 per year per lab for up to two years

 

POSTED DATE

December 6, 2021

 

DEADLINE FOR APPLICATION

January 28, 2022

 

ANTICIPATED AWARD DATE

April 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for pilot grant funding. The purpose of this call for applications is to fund innovative projects that aim to develop new or leverage existing modalities to deliver genetic payloads to pancreatic islet cells for the therapy of type 1 diabetes. Collaborative proposals are welcome, particulary where one of the labs has expertise in diabetes research. The HSCI diabetes Program intends to award up to two grants in response to this call for proposals, contingent upon the number and quality of the proposals received.... Read more about Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Targeted cargo delivery to pancreatic islet cells'

Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Learning from cancer immunology to cure autoimmune diabetes'

November 30, 2021

CALL FOR PROPOSALS

2022 HSCI DIABETES PROGRAM PILOT GRANTS

 

'Learning from cancer immunology to cure autoimmune diabetes'

 

AWARD AMOUNT

Up to $100,000 per year per lab for up to two years

 

POSTED DATE

December 6, 2021

 

DEADLINE FOR APPLICATION

January 28, 2022

 

ANTICIPATED AWARD DATE

April 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for pilot grant funding. The purpose of this call for applications is to fund innovative projects rooted in our understanding of tumor-immune interactions to avert the immune attack on pancreatic islet cells that underlies type 1 diabetes. A particular focus of the Diabetes Program lies in developing solutions that will enable the transplantation of stem cell-derived islet cells into patients with autoimmune diabetes. Approaches of interest include – but are not limited to – novel immune interventions to regulate or eliminate autoreactive T lymphocytes, interventions to modify local antigen presentation, and genetic manipulations of stem cell-derived islet cells to protect them against allo- and autoimmunity. Collaborative proposals are welcome, particulary where one of the labs has expertise in diabetes research. The HSCI diabetes Program intends to award up to two grants as a result of this call for proposals.... Read more about Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Learning from cancer immunology to cure autoimmune diabetes'

2022 HSCI Nervous System Disease Program Request for Proposals on Vision Repair and Regeneration

November 22, 2021

2022 HSCI Nervous System Disease Program

Request for Proposals on Vision Repair and Regeneration

 

AWARD AMOUNT

Trainee Awards will be made in amounts of up to $75,000 total funding per year.

Faculty Awards will be made in amounts of up to $150,000 total funding per year.

Up to $300,000 for entire project period.

Project period not to exceed 2 years

 

DEADLINE FOR LETTER OF INTENT

Wednesday, January 5, 2022

 

DEADLINE FOR FULL PROPOSAL

Friday, February 4, 2022

 

ANTICIPATED AWARD DATE

April 1, 2022

 

... Read more about 2022 HSCI Nervous System Disease Program Request for Proposals on Vision Repair and Regeneration

Call for Proposals: 2021 HSCI Musculoskeletal Disease Program Pilot Grants

October 8, 2021

CALL FOR PROPOSALS

2021 HSCI MUSCULOSKELETAL DISEASE PROGRAM PILOT GRANTS

 

AWARD AMOUNT
Up to $100,000 for entire project period
Project period not to exceed two years

POSTED DATE
Friday, October 8, 2021
DEADLINE FOR APPLICATION
Friday, November 12, 2021
ANTICIPATED AWARD DATE
January 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Musculoskeletal (MSK) Disease Program invites applications for pilot grant funding. The purpose of this program is to provide funding for innovative projects in the field of musculoskeletal stem cell and regenerative biology. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures for musculoskeletal injuries or disease. However, proposals at all stages of development are welcome, as are proposals that encompass a collaboration between two MSK labs where at least one of the labs is member of the HSCI. The HSCI MSK Program intends to award up to two grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI MSK Disease Program funds.... Read more about Call for Proposals: 2021 HSCI Musculoskeletal Disease Program Pilot Grants

Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

June 21, 2021

CALL FOR PROPOSALS

FALL 2021 HSCI COLLABORATIVE SEED GRANTS

 

AWARD AMOUNT
$100,000 per project per year for up to two years
POSTED DATE
Monday, June 21, 2021
DEADLINE FOR APPLICATION
Friday, September 17, 2021
ANTICIPATED AWARD DATE
Monday, November 1, 2021

 

The Harvard Stem Cell Institute (HSCI) invites applications for seed grant funding for its Fall 2021 cycle.

The purpose of this program is to provide funding for innovative projects in the field of stem cell and regenerative biology that are a collaboration between two labs. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures. However, proposals at all stages of development are welcome. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.... Read more about Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

Call for Proposals: P01 Pilot Grants 2021

January 20, 2021

The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) invites applications for Pilot Grant funding for 2021 under the NIH-funded P01 grant “Dissecting the establishment and regulation of human pluripotency” (PI Alexander Meissner).

The purpose of this funding program is to provide resources for proof-of-concept studies. These pilot grants are intended to increase our understanding of the basic biology of human pluripotent cells and their utility for translational applications.... Read more about Call for Proposals: P01 Pilot Grants 2021

  •  
  • 1 of 14
  • »